Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Nanjing Sanhome Pharmaceutical, Co., Ltd.)"
Count: 18
Selected: 0
NCT IDTitle
NCT05015309A Study to Investigate Safety and Tolerability of SH3765 Tablet in Patients With Advanced Malignant Tumor
NCT04843033A Study to Investigate Safety and Tolerability of SH3809 Tablet in Patients With Advanced Solid Tumors
NCT04810533The Absorption, Metabolism and Excretion of [14C]SH-1028 in Chinese Healthy Male Volunteers
NCT04808648The Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SH-1028
NCT04806659A Phase 1 Study of SH1573 Capsules in Subjects With Refractory or Relapsed Acute Myelogenous Leukemia
NCT04470141A Study of SHC014748M in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma
NCT04431089Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma
NCT04423380A Study to Investigate Safety and Tolerability of SH3051 Capsule in Patients With Advanced Solid Tumors
NCT04239833A Study of SH-1028 Tablets Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
NCT04070235SH229 Tablets Combined With Daclatasvir Dihydrochloride Tablets in Treatment Adult Patients With Chronic Hepatitis C
NCT04006860A Food-Effect Study of SHC014748M in Healthy Subjects
NCT03973632Pharmacokinetic Study of SH-1028 Tablets in Healthy Subjects Under Fasting and Fed Conditions
NCT03823807A Study to Evaluate the Safety and Efficacy of SH-1028 in Locally Advanced or Metastatic NSCLC
NCT03748745A Drug-drug Interaction Study of SH229 Tablets and Daclatasvir Dihydrochloride Tablets in Healthy Subjects
NCT03618043Safety and Tolerability of SH-1028 in Patients With Advanced Solid Cancer
NCT03603262Safety, Tolerability and Pharmacokinetics of SH-1028 in Patients With Advanced NSCLC
NCT03588923Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of SH229 in Patients With HCV Infection
NCT03588598Safety, Tolerability, and Pharmacokinetics of SHC014748M in Patients With Indolent B-Cell Hematologic Malignancies